Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
EMA Decision Due For Minoryx’s Leriglitazone & Apellis’ Pegcetacoplan
Jan 22 2024
•
By
Eliza Slawther
The EMA's Human medicines committee will meet this week to decide which drugs should be approved in the EU • Source: Shutterstock
More from Approvals
More from Product Reviews